<?xml version="1.0" encoding="UTF-8"?>
<included>
<!-- start of a new study -->
<study>
<citation year="2008" pmid="18096708" trialregistration="" journal_abbrev="Am J Respir Crit Care Med">Nobre</citation>
 <design>randomized controlled trial</design>
 <patients total="79">
 <description>suspected severe sepsis or septic shock admitted to the ICU</description>
 <bullet>Mean age 25 months</bullet>
 </patients>
 <intervention>antibiotics were stopped when PCT levels had decreased 90% or
more from the initial value (if clinicians agreed) but not before Day 3
(if baseline PCT levels were,1 mg/L) or Day 5 (if baseline PCT levels
were >1 mg/L). </intervention>
 <comparison>usual care
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>duration of antibiotic treatment, antibiotic exposure days,
 days alive without antibiotics</bullet>
 <bullet type='secondary'>28-day mortality, in-hospital mortality,
length of stay in the ICU and hospital, clinical cure, reoccurrence of the initial infection, and nosocomial
superinfection</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2009" pmid="19034493" trialregistration="" journal_abbrev="Langenbecks Arch Surg">Schroeder</citation>
 <design>randomized controlled trial</design>
 <patients total="27">
 <description>surgical intensive care
patients with severe sepsis</description>
 <bullet>Mean age 69.3 years</bullet>
 </patients>
 <intervention> PCT <1 ng/mL and clinical signs of infection improved: antibiotics discontinued
PCT dropped to <35% of the initial concentration within 3 days and clinical signs of infection improved: antibiotics discontinued
 </intervention>
 <comparison>usual care
 </comparison>
 <outcome> 
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>Length of antibiotic treatment (days)</bullet>
 <bullet type='secondary'>cost of antibiotic treatment</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2009" pmid="19493352" trialregistration="" journal_abbrev="Crit Care">Hochreiter</citation>
 <design>randomized controlled trial</design>
 <patients total="110">
 <description> SICU patients with confirmed or highly suspected bacterial infections
 and at least two concomitant systemic inflammatory response syndrome
criteria</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention>
 Antibiotics discontinued, if clinical signs and symptoms of infection
improved and PCT decreased to <1 ng/ml or the PCT value was
>1 ng/ml, but had dropped to 25 to 35% of the initial value over
three days. 
 </intervention>
 <comparison>standard regimen of antibiotics over 8 days
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>length of antibiotic treatment</bullet>
 <bullet type='secondary'>Criteria used or how measured?</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2010" pmid="20097417" trialregistration="" journal_abbrev="Lancet">Bouadma</citation>
 <design>randomized controlled trial</design>
 <patients total="621">
 <description>critically ill patients with suspected bacterial infections in ICU</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention>predefined algorithms to guide
physicians to start or discontinue antibiotics according to
serum procalcitonin concentrations; discontinue
antibiotics when procalcitonin concentration was less
than 80% of the peak concentration or an absolute
concentration of less than 0∙5 μg/L was reached.
 </intervention>
 <comparison>usual care
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>mortality at days 28 and 60 (non-inferiority analysis),
 and number of days without antibiotics by day 28 (superiority analysis)</bullet>
 <bullet type='secondary'>percentage of patients with relapse or superinfection
(days 1–28); number of days without mechanical
ventilation, defi ned as unassisted breathing (days 1–28);
SOFA score (days 1, 7, 14, 21, and 28); length of stay in the
intensive care unit and hospital; days of exposure to each
antibiotic per 1000 inpatient days, defi ned as the number
of days (>24 h) of continuous antibiotic treatment (days 1–28);
duration of antibiotic treatment according to infection
site; and percentage of emerging multidrug-resistant
bacteria isolated from specimens taken for routine
microbiological assessments (days 1–28).</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2013" pmid="23418298" trialregistration="" journal_abbrev="BMJ Open">Annane</citation>
 <design>randomized controlled trial</design>
 <patients total="62">
 <description>non-microbiologically proven apparent severe sepsis in ICU</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention> initiation and discontinuation of antibiotics guided by a PCT-based algorithm
 <bullet>Amount?</bullet>
 <bullet>Frequency?</bullet>
 <bullet>Duration?</bullet>
 </intervention>
 <comparison>usual care
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>proportion of patients 
 receiving antibiotics at day 5 postrandomisation</bullet>
 <bullet type='secondary'>Secondary outcomes included death at day 5, at ICU
discharge and at hospital discharge, the proportion of
patients started on antibiotics postrandomisation, the
duration of antibiotic exposure, the SOFA score at day 3
and day 5, the proportion of patients with infection
acquired between randomisation and day 3, day 5 and
ICU discharge, and ICU and hospital length-of-stay.</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2013" pmid="23921272" trialregistration="" journal_abbrev="Crit Care Med">Oliveira</citation>
 <design>randomized controlled trial</design>
 <patients total="94">
 <description>suspected severe sepsis or septic shock in ICU</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention>procalcitonin-guided therapy
 <bullet>Amount?</bullet>
 <bullet>Frequency?</bullet>
 <bullet>Duration?</bullet>
 </intervention>
 <comparison>protocol based on the serum levels of CRP
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>duration of antibiotic therapy
for the first episode of infection</bullet>
 <bullet type='secondary'>1) total number of days on antibiotic therapy; 2)
days off antibiotic therapy; 3) death from any cause during the
28 days of follow-up in the hospital; 4) length of stay (LOS) in
the ICU and LOS in the hospital; and 5) clinical cure, recurrent
infection, and nosocomial infection.</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2014" pmid="25295709" trialregistration="" journal_abbrev="Am J Respir Crit Care Med">Shehabi</citation>
 <design>randomized controlled trial</design>
 <patients total="394">
 <description>suspected bacterial infection/sepsis in ICU</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention>PCT algorithm with a cut-off of 0.1 ng/ml
 <bullet>Amount?</bullet>
 <bullet>Frequency?</bullet>
 <bullet>Duration?</bullet>
 </intervention>
 <comparison>usual care
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>time to antibiotic
cessation at 28 days, hospital discharge, or death</bullet>
 <bullet type='secondary'> number of antibiotic daily defined doses (DDD) at Day 28,
ICU and hospital length of stay, mortality and 90-day all-cause
mortality</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2013" pmid=" 23711530" trialregistration="" journal_abbrev="Diagnostic Microbiology and Infectious Disease">Deliberato</citation>
 <design>randomized controlled trial</design>
 <patients total="81">
 <description>microbiologically confirmed infections with
sepsis, severe sepsis, and septic shock in ICU</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention>PCT protocol: encourage the physician to discontinue the
antibiotics when: 1) PCT dropped more than 90% from the peak level
or 2) an absolute value of 0.5 ng/mL was reached
 </intervention>
 <comparison>usual care
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>duration of antibiotic therapy</bullet>
 <bullet type='secondary'> in-hospital mortality, ICU
mortality, ICU length of stay, recurrence of the initial infection,
analysis of the CRP levels along with the PCT protocol, and costs.</bullet>
 </outcome>
</study>
<!-- start of a new study -->
<study>
<citation year="2014" pmid="25295709" trialregistration="" journal_abbrev="Am J Respir Crit Care Med">Shehabi</citation>
 <design>randomized controlled trial</design>
 <patients total="394">
 <description>suspected bacterial infection/sepsis in ICU</description>
 <bullet>Mean age __ months</bullet>
 </patients>
 <intervention>PCT algorithm with a cut-off of 0.1 ng/ml
 <bullet>Amount?</bullet>
 <bullet>Frequency?</bullet>
 <bullet>Duration?</bullet>
 </intervention>
 <comparison>usual care
 </comparison>
 <outcome>
 <bullet type='primary' url='http://pubmed.gov/delete_url_if_not_needed'>time to antibiotic
cessation at 28 days, hospital discharge, or death</bullet>
 <bullet type='secondary'> number of antibiotic daily defined doses (DDD) at Day 28,
ICU and hospital length of stay, mortality and 90-day all-cause
mortality</bullet>
 </outcome>
</study>
<!-- Leave this bottom line -->
</included>
